The chronic lymphocytic leukemia therapeutics market is expected to grow at a compound annual growth rate of 7% from 2025 to 2030. This growth is fueled by innovations in targeted therapies, an increase in CLL incidence rates globally, expanded research into immunotherapy solutions, and f